Economic burden of cancer in China: causes and reflection
-
摘要: 近年来,我国癌症发病人数和死亡人数持续上升,给患者、家庭及社会带来了沉重的经济负担。本文从我国目前癌症发病情况及相关的社会因素等方面分析我国癌症经济负担沉重的主要成因,并对未来降低我国癌症经济负担提出意见和建议。Abstract: Over recent years in China, the incidence and mortality of cancer have increased significantly, bringing a heavy economic burden on patients, patients' families and society. In this paper, we analyze main causes and heavy economic burden of cancer in China from aspects of disease characteristics and related social factors, and put forward suggestions on reducing the economic burden of cancer in China in the future.
-
[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016, 66(2): 115 – 132. doi: 10.3322/caac.21338 [2] 郑荣寿, 顾秀瑛, 李雪婷, 等. 2000 — 2014年中国肿瘤登记地区癌症发病趋势及年龄变化分析[J]. 中华预防医学杂志, 2018, 52(6): 593 – 600. doi: 10.3760/cma.j.issn.0253-9624.2018.06.007 [3] World Health Organization, Cancer Today – International Agency for Research on Cancer[DB/OL]. (2020 – 12 – 15) [2022 – 05 – 30].https://gco.iarc.fr/today/online-analysis-table?v=2020&mode=population&mode_population=countries&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=0&include_nmsc_other=1. [4] 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 国家卫生健康委统计信息中心. 中国死因监测数据集2019[M]. 北京: 中国科学技术出版社, 2020. [5] Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. Journal of the National Cancer Center, 2022, 2(1): 1 – 9. doi: 10.1016/j.jncc.2022.02.02 [6] 史玥. 我国西南部某地区恶性肿瘤疾病经济负担研究[D]. 上海: 华北理工大学, 2019. [7] Hofmarcher T, Lindgren P, Wilking N, et al. The cost of cancer in Europe 2018[J]. European Journal of Cancer, 2020, 129: 41 – 49. doi: 10.1016/j.ejca.2020.01.011 [8] Jemal A, Torre L, Soerjomataram I, et al. The cancer atlas[M]. 250 Williams Street Atlanta, Georgia 30303 USA: The American Cancer Society, 2019. [9] Cai Y, Xue M, Chen WQ, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015[J]. Chinese Journal of Cancer Research, 2017, 29(3): 253 – 262. doi: 10.21147/j.issn.1000-9604.2017.03.11 [10] Venkatesan P. Cancer-related productivity losses in BRICS countries[J]. The Lancet Oncology, 2018, 19(3): e147. doi: 10.1016/S1470-2045(18)30090-1 [11] Chen WQ, Xia CF, Zheng RS, et al. Disparities by province, age, and sex in site - specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment[J]. The Lancet Global Health, 2019, 7(2): e257 – e269. doi: 10.1016/S2214-109X(18)30488-1 [12] Liu J, Liang WN, Jing WZ, et al. Countdown to 2030: eliminating hepatitis B disease, China[J]. Bulletin of the World Health Organiza-tion, 2019, 97(3): 230 – 238. doi: 10.2471/BLT.18.219469 [13] Shi JF, Cao MM, Wang YT, et al. Is it possible to halve the incidence of liver cancer in China by 2050?[J]. International Journal of Cancer, 2021, 148(5): 1051 – 1065. doi: 10.1002/ijc.33313 [14] 潘锋. 我国肝癌主要病因预防取得长足进展 —— 访国家癌症中心/中国医学科学院肿瘤医院曲春枫教授[J]. 中国医药导报, 2022, 19(17): 1 – 4. [15] Serrano B, Brotons M, Bosch FX, et al. Epidemiology and burden of HPV - related disease[J]. Best Practice and Research Clinical Obstetrics and Gynaecology, 2018, 47: 14 – 26. doi: 10.1016/j.bpobgyn.2017.08.006 [16] 赵今朝. 广东推动适龄女生免费接种HPV疫苗全国数地先行先试[N]. 财新网, 2021 – 10 – 28. [17] 赵为德. 15个健康中国试点城市中, 6个城市已启动HPV疫苗免费或补助接种[N]. 健康时报网, 2021 – 11 – 27. [18] World Health Organization. Global adult tobacco survey fact sheet[R]. Geneva, Switzerland: World Health Organization, 2019. [19] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA: A Cancer Journal for Clinicians, 2021, 71(1): 7 – 33. doi: 10.3322/caac.21654 [20] Huang HY, Shi JF, Guo LW, et al. Expenditure and financial burden for common cancers in China: a hospital - based multicentre cross - sectional study[J]. The Lancet, 2016, 388: S10. [21] Cao MM, Li H, Sun DQ, et al. Cancer screening in China: the current status, challenges, and suggestions[J]. Cancer Letters, 2021, 506: 120 – 127. doi: 10.1016/j.canlet.2021.02.017 [22] 谢娜, 彭晔, 韩轶超, 等. 恶性肿瘤规范化诊疗质控结果分析[J]. 中国卫生质量管理, 2014, 21(5): 28 – 30. doi: 10.13912/j.cnki.chqm.2014.21.5.09 [23] 谢丰婴, 王岳. 医学创新的自由要有界限[J]. 中国卫生, 2021(6): 58 – 59. doi: 10.15973/j.cnki.cn11-3708/d.2021.06.027 [24] 邱亭林, 林伟龙, 马建辉, 等. 肿瘤规范化诊治现状及质量控制管理探讨[J]. 中国肿瘤, 2018, 27(5): 343 – 346. doi: 10.11735/j.issn.1004-0242.2018.05.A005 [25] Yip W, Fu HQ, Chen AT, et al. 10 years of health - care reform in China: progress and gaps in Universal Health Coverage[J]. The Lancet, 2019, 394(10204): 1192 – 1204. doi: 10.1016/S0140-6736(19)32136-1 [26] 中国药学会. 中国药学会医院用药监测报告 —— 化药与生物制品部分2020年上半年[R]. 北京: 中国药学会, 2020. [27] Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval[J]. JAMA Internal Medicine, 2017, 177(11): 1569 – 1575. doi: 10.1001/jamainternmed.2017.3601 [28] Huang HY, Wu DW, Ma F, et al. Availability of anticancer biosimilars in 40 countries[J]. The Lancet Oncology, 2020, 21(2): 197 – 201. doi: 10.1016/S1470-2045(19)30860-5 [29] 李华强, 庄易霖, 范春梅. 基于扎根理论的“天价药”形成机理与政府监管策略研究[J]. 中国行政管理, 2020(5): 140 – 145. doi: 10.19735/j.issn.1006-0863.2020.05.20 [30] 谢明明. 我国基本医疗保险全覆盖的挑战及对策[J]. 中国医疗保险, 2020(1): 13 – 17. doi: 10.19546/j.issn.1674-3830.2020.1.004 [31] 国家医疗保障局. 2020年全国医疗保障事业发展统计公报[R]. 北京: 国家医疗保障局, 2021. [32] 国家医疗保障局. 2019年全国医疗保障事业发展统计公报[R]. 北京: 国家医疗保障局, 2020. [33] 王佳慧, 尹航, 张鑫, 等. 中国2013年主要慢性病住院患者自付费用与报销费用分析[J]. 中国公共卫生, 2021, 37(4): 623 – 626. doi: 10.11847/zgggws1127072 [34] 国家卫生健康委员会. 2020中国卫生健康统计年鉴[M]. 北京: 中国协和医科大学出版社, 2021. [35] 财新网. 健康中国无烟立法进行时[DB/OL]. (2022 – 05 – 20)[2022 – 05 – 30].https://datanews.caixin.com/interactive/2020/smokefree-digital-map/. [36] 孔敏. 浅析中国控烟履约工作开展现状[J]. 中国经贸导刊, 2015(8): 53 – 55. doi: 10.3969/j.issn.1007-9777.2015.08.020 [37] 都恩环, 雷海潮. 提高烟草税对我国卷烟消费影响的实证研究[J]. 中国卫生经济, 2020, 39(6): 65 – 68. [38] Huang HY, Miao HL, Wang J, et al. Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval[J]. Journal of the National Cancer Center, 2021, 1(4): 147 – 152. doi: 10.1016/j.jncc.2021.08.002 [39] 国家卫生健康委办公厅, 国家中医药局办公室, 中央军委后期保障部卫生局. 肿瘤诊疗质量提升行动计划. 国卫办医函[2021]513号[EB/OL]. (2021 – 09 – 26). http://www.nhc.gov.cn/yzygj/s7659/202110/dea7d84638db44e28001fbd7d6c6801a.shtml. [40] 张涛. 总额预付下公立综合医院医疗服务供给的影响机制与管理策略研究[D]. 武汉: 华中科技大学, 2021.
点击查看大图
计量
- 文章访问数: 561
- HTML全文浏览量: 665
- PDF下载量: 180
- 被引次数: 0